A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : NIAID / National Institute of Allergy and Infectious Diseases

[Related PubMed/MEDLINE]
Total Number of Papers: 219
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   NIAID  (>> Co-occurring Abbreviation)
Long Form:   National Institute of Allergy and Infectious Diseases
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2023 Anthony Fauci: a scientific adviser's role from HIV to COVID-19. ---
2022 A single-shot ChAd3-MARV vaccine confers rapid and durable protection against Marburg virus in nonhuman primates. CDC, ChAd3, MARV
2022 Anaphylaxis among elderly emergency department patients in a large health system in New York. AARs, EDs
2022 Animal Care in Radiation Medical Countermeasures Studies. BARDA, FDA, MCM
2022 Bibliometric Analysis and Visualization Mapping of Anthrax Vaccine Publications from 1991 through 2021. HHS, NIH, UK, USA, WoSCC
2022 Clinical effects of durability of immunosuppression in virologically suppressed ART-initiating persons with HIV in Latin America. A retrospective cohort study. aHR, CI, FIC, FIMP, leDEA, NCI, NHLBI, NIAAA, NICHD, NIDDK, NIMH, PWH, VS
2022 HIV/AIDS Community Information Outreach Program (ACIOP): A Landmark NIH Conference and an Enduring NLM Role in Meeting the Affected Community's Need for Information Access. ACIOP, NIH, NLM, OAR
2022 HIV/AIDS community information outreach program (ACIOP): A landmark NIH conference and an enduring NLM role in meeting the affected community's need for information access. ACIOP, NIH, NLM, OAR
2022 Identification of beta-Lactams Active against Mycobacterium tuberculosis by a Consortium of Pharmaceutical Companies and Academic Institutions. IDRI, Mtb, TB, TBDA
10  2022 Impact of extramural DAIT/NIAID pharmacy programs, research pharmacist scientist oversight on study performance, and lessons learned. CG, DAIT, IG, IP
11  2022 Inter-agency perspective: Translating advances in biomarker discovery and medical countermeasures development between terrestrial and space radiation environments. NASA, NCI
12  2022 Introducing the Bacterial and Viral Bioinformatics Resource Center (BV-BRC): a resource combining PATRIC, IRD and ViPR. BRC, BV-BRC, IRD, PATRIC, ViPR
13  2022 NIH Policies and Regulatory Pathways to U.S. FDA licensure: Strategies to Inform Advancement of Radiation Medical Countermeasures and Biodosimetry Devices. MCMs, RNCP
14  2022 Safety, Immunogenicity and Efficacy of NVX-CoV2373 in Adolescents in PREVENT-19: A Randomized, Phase 3 Trial. CI, NA, VE
15  2022 SARS-CoV-2 Omicron virus causes attenuated disease in mice and hamsters. hACE2, SAVE
16  2022 The SARS-CoV-2 B.1.1.529 Omicron virus causes attenuated infection and disease in mice and hamsters. hACE2, SAVE
17  2022 Variation in blood microbial lipopolysaccharide (LPS) contributes to immune reconstitution in response to suppressive antiretroviral therapy in HIV. ART, i.p, INRs, LPS, MS, TLR
18  2022 Visual representations of SARS-CoV-2, emotions, and risk perception of COVID-19. CDC, MTurk
19  2022 [Remdesivir for COVID-19]. MERS, SARS
20  2021 A Trans-Agency Workshop on the Pathophysiology of Radiation-Induced Lung Injury. BARDA, FDA, MCMs, RNCP
21  2021 A Trans-Agency Workshop on the Pathophysiology of Radiation-Induced Lung Injury. Animal Rule, BARDA, FDA, MCMs, RILI, RNCP
22  2021 Antibody affinity maturation and cross-variant activity following SARS-CoV-2 mRNA vaccination: Impact of prior exposure and sex. MCMi, NIH, PsVNA, RBD, SPR, US, VOCs, VOIs
23  2021 CCR5-edited CD4+ T cells augment HIV-specific immunity to enable post-rebound control of HIV replication. ART, NIDA, NIMH, NINDS, ZFN
24  2021 Challenges and Strategies in the Development of Radiation Biodosimetry Tests for Patient Management. BARDA, FDA, HHS, NIH, PHEMCE
25  2021 Development of Biomarkers for Radiation Biodosimetry and Medical Countermeasures Research: Current Status, Utility, and Regulatory Pathways. MCMs, RNCP
26  2021 Fecal microbiome and metabolome differ in healthy and food-allergic twins. OTUs
27  2021 IL-6 receptor blockade does not slow beta cell loss in new-onset type 1 diabetes. CTSA, NCATS, NCRR, NIDDK
28  2021 Interagency approaches to animal models for acute radiation exposure. BARDA, MCMs, NASA, NHPs
29  2021 Management of pediatric allergic reaction: Practice patterns of Canadian pediatric emergency physicians. PEM, PERC
30  2021 Methodological and Measurement Advances in Social Determinants of HIV: View from NIH. NIMH
31  2021 Neutron Radiobiology and Dosimetry. DoD, DTRA, MCMs, NASA, RNCP
32  2021 Risk Factors for HIV sero-conversion in a high incidence cohort of men who have sex with men and transgender women in Bangkok, Thailand. aHR, DAIDS, MSM, TGW
33  2021 SARS-CoV-2 incidence and risk factors in a national, community-based prospective cohort of U.S. adults. CI
34  2020 A clade of SARS-CoV-2 viruses associated with lower viral loads in patient upper airways. COVID-19, NUCATS
35  2020 A Unique Clade of SARS-CoV-2 Viruses is Associated with Lower Viral Loads in Patient Upper Airways. COVID-19, NUCATS
36  2020 Application of a Sanger-Based External Quality Assurance Strategy for the Transition of HIV-1 Drug Resistance Assays to Next Generation Sequencing. EQA, HIVDR, NGS, SS, VQA, WHO
37  2020 Are primary care physicians following National Institute of Allergy and Infectious Disease guidelines for the prevention of peanut allergy? A survey-based study. CI, OR
38  2020 Broadly Protective Strategies Against Influenza Viruses: Universal Vaccines and Therapeutics. ---
39  2020 Characterizing Emerging Canine H3 Influenza Viruses. CEIRS, hmAbs
40  2020 Cutaneous Radiation Injuries: Models, Assessment and Treatments. BARDA, FDA, MCM
41  2020 Exome sequencing study in a clinical research setting finds general acceptance of study returning secondary genomic findings with little decisional conflict. SF
42  2020 Foreign Body Aspiration Presenting as Pneumothorax in a Child. AAP, FBA, RSV
43  2020 Inhibiting Glycogen Synthase Kinase-3 Mitigates the Hematopoietic Acute Radiation Syndrome in a Sex- and Strain-dependent Manner in Mice. ARS, G-CSF, GI, GSK-3, HSPCs, SBI, TBI
44  2020 Insights of Novel Coronavirus (SARS-CoV-2) disease outbreak, management and treatment. AI, GIS, RT-PCR, SARS-CoV, SARS-CoV-2
45  2020 NIAID's Comprehensive Support Mechanisms for Antibiotic Development. ---
46  2020 Pros and cons of pre-emptive screening programmes before peanut introduction in infancy. ---
47  2020 Repurposing Anti-Cancer Drugs for COVID-19 Treatment. ACTT, COVID-19, FDA
48  2020 Robust antibody and cellular responses induced by DNA-only vaccination for HIV. EP, ID, IM, pIL-12
49  2020 Structure-Based Design with Tag-Based Purification and In-Process Biotinylation Enable Streamlined Development of SARS-CoV-2 Spike Molecular Probes. NCCAT, PBMCs, SEMC
50  2020 The association of alpha4beta7 expression with HIV acquisition and disease progression in people who inject drugs and men who have sex with men: Case control studies. adjOR, CI, MSM, PWID
51  2020 The National Institutes of Health Chemical Countermeasures Research Program (NIH CCRP): A collaborative opportunity to develop effective and accessible chemical medical countermeasures for the American people. CCRP, HHS, MCMs, NIH CCRP
52  2020 The technology behind TB DEPOT: a novel public analytics platform integrating tuberculosis clinical, genomic, and radiological data for visual and statistical exploration. FAIR, TB, TB DEPOT
53  2019 51 years in of Chikungunya clinical vaccine development: A historical perspective. CHIKF, CHIKV
54  2019 Adoptive lymphocyte transfer to an HIV-infected progressor from an elite controller. ---
55  2019 AIDS Vaccine Research Subcommittee (AVRS) Consultation: Early-Life Immunization Strategies against HIV Acquisition. AVRS, bNAbs, NIH
56  2019 Engineering immunity for next generation HIV vaccines: The intersection of bioengineering and immunology. NIBIB
57  2019 Follicular T helper cells shape the HCV-specific CD4+ T cell repertoire after virus elimination. HCV
58  2019 Future epidemiological and economic impacts of universal influenza vaccines. ---
59  2019 Highlights from the Fourth Biennial Strategies for an HIV Cure Meeting, 10-12 October 2018, Bethesda, MD, USA. MDCs, NIH
60  2019 Immunological mechanisms of inducing HIV immunity in infants. bNAbs, NIH
61  2019 Use of Growth Factors and Cytokines to Treat Injuries Resulting from a Radiation Public Health Emergency. MCM
62  2019 Use of Growth Factors and Other Cytokines for Treatment of Injuries During a Radiation Public Health Emergency. MCM, RITN
63  2018 Assessing effects of behavioral intervention on treatment outcomes among patients initiating HIV care: Rationale and design of iENGAGE intervention trial. ART, iENGAGE, PLWH, US, VS
64  2018 Challenges and Benefits of Repurposing Products for Use during a Radiation Public Health Emergency: Lessons Learned from Biological Threats and other Disease Treatments. MCMs
65  2018 Ethical considerations for HIV cure-related research at the end of life. EOL, NIMH, PLWHIV, UCSD
66  2018 Exploration of (hetero)aryl Derived Thienylchalcones for Antiviral and Anticancer Activities. DENV-2, DTP, HBV, HCMV, HSV-1, PV 1, RVF, RVFV, TCRV, VEE, ZIKV
67  2018 Hepatitis C Virus Database and Bioinformatics Analysis Tools in the Virus Pathogen Resource (ViPR). HCV, ViPR
68  2018 Innovative approaches to track lymph node germinal center responses to evaluate development of broadly neutralizing antibodies in human HIV vaccine trials. bNAbs, FNA, GC
69  2018 Subtype C ALVAC-HIV and bivalent subtype C gp120/MF59 HIV-1 vaccine in low-risk, HIV-uninfected, South African adults: a phase 1/2 trial. Env, HVTN
70  2018 The diagnosis and management of food allergies. Position paper of the Food Allergy Section the Polish Society of Allergology. EAACI
71  2018 Use of External Quality Control Material for HIV-1 RNA Testing To Assess the Comparability of Data Generated in Separate Laboratories and the Stability of HIV-1 RNA in Samples after Prolonged Storage. ACTG, CI, MWP, VQA
72  2017 "The Impact of Mycobacterium tuberculosis Immune Evasion on Protective Immunity: Implications for TB Vaccine Design" - Meeting report. Abs, BCG, Mtb, TB
73  2017 A human time dose response model for Q fever. CDC
74  2017 A Web-Based Data Collection Platform for Multisite Randomized Behavioral Intervention Trials: Development, Key Software Features, and Results of a User Survey. iENGAGE
75  2017 Highlights from the Third Biennial Strategies for an HIV Cure Meeting: 14-16 November 2016, Bethesda, MD, USA. CIAR, MDC
76  2017 Identification of Novel 5,6-Dimethoxyindan-1-one Derivatives as Antiviral Agents. ---
77  2017 Nephele: a cloud platform for simplified, standardized and reproducible microbiome data analysis. HMP
78  2017 Pediatric Anaphylaxis in the Emergency Department: Clinical Presentation, Quality of Care, and Reliability of Consensus Criteria. ED, IRR
79  2017 Prediction of promiscuous T cell epitopes in RNA dependent RNA polymerase of Chikungunya virus. CHIKV, HLA, IEDB
80  2017 Prediction of virus-host protein-protein interactions mediated by short linear motifs. HIV-1
81  2017 The Pathway to a Universal Influenza Vaccine. ---
82  2017 Waning Immunity and Microbial Vaccines-Workshop of the National Institute of Allergy and Infectious Diseases. ---
83  2017 Workshop report: Nucleic acid delivery devices for HIV vaccines: Workshop proceedings, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland, USA, May 21, 2015. AIDS, HIV, N-S, NA
84  2016 A survey of tuberculosis infection control practices at the NIH/NIAID/DAIDS-supported clinical trial sites in low and middle income countries. IC, LMIC, TB, TB IC
85  2016 Antithymocyte globulin therapy for patients with recent-onset type 1 diabetes: 2year results of a randomised trial. AE, ATG, ITN, NIH
86  2016 Challenges and opportunities in RSV vaccine development: Meeting report from FDA/NIH workshop. CBER, ERD, HIC, LMIC, RSV
87  2016 Dengue vaccines: Are they safe for travelers? DENV
88  2016 Effects of a multicomponent intervention to streamline initiation of antiretroviral therapy in Africa: a stepped-wedge cluster-randomised trial. ART
89  2016 Influenza Research Database: An integrated bioinformatics resource for influenza virus research. HA, IRD
90  2016 Next-Generation High-Throughput Functional Annotation of Microbial Genomes. ---
91  2016 Solving Immunology? ---
92  2016 Summary and Recommendations from the National Institute of Allergy and Infectious Diseases (NIAID) Workshop "Gonorrhea Vaccines: the Way Forward". CDC, GC
93  2016 Temporal and Racial Differences Associated with Atopic Dermatitis Staphylococcusaureus and Encoded Virulence Factors. AA, AD, ADRN, EA, egc, MA, SAgs, TSS, TSST-1
94  2016 Toward an Evidence-Based Nonclinical Road Map for Evaluating the Efficacy of New Tuberculosis (TB) Drug Regimens: Proceedings of a Critical Path to TB Drug Regimens-National Institute of Allergy and Infectious Diseases In Vivo Pharmacology Workshop for TB Drug Development. CPTR, TB
95  2016 Understanding the Pathophysiology and Challenges of Development of Medical Countermeasures for Radiation-Induced Vascular/Endothelial Cell Injuries: Report of a NIAID Workshop, August 20, 2015. MCMs
96  2015 Entomological Monitoring and Evaluation: Diverse Transmission Settings of ICEMR Projects Will Require Local and Regional Malaria Elimination Strategies. ---
97  2015 Exploring immunological mechanisms of the whole sporozoite vaccination against P. falciparum malaria. CHMI, PfSPZ
98  2015 Virological response after 6 week triple-drug regimens for hepatitis C: a proof-of-concept phase 2A cohort study. HCV, SVR12
99  2014 Bovine rotavirus pentavalent vaccine development in India. BRV-PV
100  2014 Recognition and first-line treatment of anaphylaxis. FAAN, ICD